Upon coinjection with 50 μg AMD3100, tumor accumulation is reduced to background levels (Fig. 5b), demonstrating that tumor uptake of [64Cu]NOTA-pentixather is almost exclusively CXCR4-mediated. Here, CXCR4 is linked to neoplasm.